Pfizer vaccine neutralizes key variants, easing one of biggest fears about pandemic

Published



The Pfizer-BioNTech vaccine appears to have a high degree of efficacy against the more transmissible variants of the coronavirus first identified in the United Kingdom and Brazil.

The study in question could ease fears that the new strains of the virus would result in another surge in the United States.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.